Context Therapeutics Inc. (CNTX) has a market capitalization of $230.62M and trades at $2.51. The 52-week range is 0.49-3.62.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.6, Earnings Per Share (EPS) of $-0.38.
The stock has a beta of 1.83, operates in the Healthcare sector.
